Merck & Co. Inc.

Pharmaceuticals
United States
Earnings Per Share Growth (%)-61.67%
Cost of Goods Sold (US$ Millions)$14,934
Current Liabilities (US$ Millions)$19,203
Total Assets (US$ Millions)$29,764
Long Term Debt$23,929
Return on Equity9.13%
Revenue (US$ Millions)$39,498
Total Company Assets$101,779
Revenue Growth (%)-6.48%
Net Income (US$ Millions)$4,442
Earnings Per Share (US$)($61.67)
Total Equity (US$ Millions)$44,676
Profit Margin (%)11.25%
Debt To Equity Ratio (%)0.54%
Inventory Turnover$4,700